Improving blood flow during cardiac arrest treatment
Endovascular blood pressure targeting in cardiac arrest, a translational research study
This study is testing a new device that helps improve blood flow to the heart and brain during and after a cardiac arrest, which could lead to better recovery for patients, especially in terms of brain function.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10893491 on NIH RePORTER |
What this research studies
This research investigates a new method to enhance blood flow to the heart and brain during and after cardiac arrest. It involves using a specialized catheter that can control blood pressure and improve perfusion while minimizing the need for epinephrine, a common medication used in resuscitation. The catheter is designed to be automated, adjusting its function based on the patient's needs, which could lead to better outcomes for those who survive cardiac arrest. The study aims to test this innovative approach in a clinical setting to see if it can improve neurological recovery.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have suffered a cardiac arrest and are undergoing resuscitation efforts.
Not a fit: Patients who are not experiencing cardiac arrest or those with severe pre-existing neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and better neurological outcomes for patients who experience cardiac arrest.
How similar studies have performed: Previous pilot studies in animal models have shown promising results with similar approaches, indicating potential for success in human applications.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Johnson, Michael Austin — University of Utah
- Study coordinator: Johnson, Michael Austin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.